Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography
Risk Management and Healthcare Policy · 2026-11 · Volume 19 · 1-11
DOI: 10.2147/rmhp.s626020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Risk Management and Healthcare Policy, 2026-11. Verfasst von Li-Yun Xu und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
To quantitatively evaluate changes in gastric antral motility before and after semaglutide administration using oral contrast-enhanced gastric ultrasonography, providing imaging-based quantitative evidence for assessing the gastrointestinal effects of semaglutide in clinical practice.
Methods
This prospective study enrolled 60 patients with obesity or diabetes mellitus who were randomly assigned to the semaglutide or control group. Gastric ultrasonography was performed at baseline, 4 weeks, and 8 weeks. Concurrently, a gastrointestinal transit test was conducted: patients ingested a barium marker capsule when 200 mL of contrast agent remained, with abdominal radiography performed at 2 and 4 hours post-ingestion.
Results
No significant between-group differences were observed at baseline. At 4 weeks following semaglutide injection, all gastric motility indices were significantly reduced ( p < 0.05), with further significant decreases at 8 weeks ( p < 0.05). Gastrointestinal transit tests demonstrated progressively increased retention of barium markers in the stomach, an elevated gastric transit index, and a decreased barium excretion rate in the semaglutide group compared with the control group (all p < 0.05).
Conclusion
Oral contrast-enhanced gastric ultrasonography provides a noninvasive, quantitative method for assessing semaglutide-associated delayed gastric emptying and reduced gastric antral motility. These effects intensify with prolonged treatment duration. Keywords: gastric antral motility, gastric ultrasonography, gastrointestinal transit test, oral gastric ultrasound contrast agent, semaglutide, delayed gastric emptying
Zitieren
APA
Xu, L., Han, D., Zhu, Y., Dong, S., Li, L., Liu, C., & Guo, J. (2026). Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography. Risk Management and Healthcare Policy, Volume 19, 1-11. https://doi.org/10.2147/rmhp.s626020
Vancouver
Xu L, Han D, Zhu Y, Dong S, Li L, Liu C, et al. Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography. Risk Management and Healthcare Policy. 2026;Volume 19:1-11. doi:10.2147/rmhp.s626020
BibTeX
@article{Xu2026,
author = {Xu, Li-Yun and Han, Dong and Zhu, Yuan-Min and Dong, Song and Li, Lin and Liu, Cui-Xia and Guo, Jun},
title = {Quantitative Evaluation of Semaglutide-Associated Changes in Gastric Antral Motility Using Oral Contrast-Enhanced Gastric Ultrasonography},
journal = {Risk Management and Healthcare Policy},
year = {2026},
volume = {Volume 19},
pages = {1--11},
doi = {10.2147/rmhp.s626020}
}
EUVIMED